Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CLX Medical to expand in European market
The master distributor will provide product support and product packaging control; coordinate sales to other European distributors; distribute products in its own territory; act as the registered EU
The master distributor will provide product support and product packaging control; coordinate sales to other European distributors; distribute products in its own territory; act as the registered EU
Net earnings for the first quarter of 2008 increased 24% to $429.4 million, or $1.43 per share on a diluted basis, compared to $346.2 million, or $1.14 per
The financing was obtained from existing investors, including Intersouth Partners, Tullis-Dickerson, Harbert Venture Partners and the Aurora Funds. The company plans to use the proceeds raised in this
The assay is performed on a Luminex cytometer using a multi-probe liquid bead array method. The liquid bead array format provides comprehensive information in a single well, providing
The plan allows Ark to develop Cerepro for operable high grade glioma in children from one month up to 18 years old. The paediatric work will not commence
This approval is claimed to be a significant milestone in the company’s continued worldwide expansion. Surgeons in China will now have access to the company’s full line of
The Deep study was designed to investigate whether treatment with a Digoxin Immune Fab (DIF) Digibind, (GlaxoSmithKline) could influence the progression of the disease by neutralizing endogenous digoxin-like
The three-year agreement, with effect from June 1, 2008, will help to introduce Medihoney Wound & Burn Dressing with active leptospermum honey to the organization’s growing customer base,
This US Phase IIb Betas trial is similar to the previously announced Canadian-based Regenesis trial. The recruitment target for this US study is to enroll 20-30 patients at
The study has used a mouse model that spontaneously forms breast cancer. These tumors develop and spread to the lungs at known developmental time points. Such models are